Cullen Investment Group LTD. Has $3.81 Million Stock Position in McKesson Corporation $MCK

Cullen Investment Group LTD. increased its position in shares of McKesson Corporation (NYSE:MCK) by 550.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,670 shares of the company’s stock after acquiring an additional 3,952 shares during the quarter. Cullen Investment Group LTD.’s holdings in McKesson were worth $3,811,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in MCK. Brighton Jones LLC boosted its stake in shares of McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson during the first quarter worth approximately $233,000. Sivia Capital Partners LLC raised its stake in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares during the last quarter. American Century Companies Inc. lifted its holdings in McKesson by 16.0% in the second quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock valued at $10,052,000 after buying an additional 1,895 shares during the period. Finally, Global Retirement Partners LLC bought a new position in McKesson in the second quarter valued at approximately $2,319,000. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of analyst reports. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Mizuho raised their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Raymond James Financial set a $970.00 price objective on McKesson in a report on Thursday, March 5th. Finally, Barclays raised their target price on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a report on Wednesday, February 18th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $960.93.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 over the last three months. Company insiders own 0.08% of the company’s stock.

McKesson Stock Down 0.3%

Shares of NYSE MCK opened at $879.57 on Thursday. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The stock has a market cap of $107.74 billion, a price-to-earnings ratio of 25.30, a P/E/G ratio of 1.42 and a beta of 0.38. The company’s fifty day moving average is $906.79 and its 200-day moving average is $837.49.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.